New Type 1 Diabetes Study Enrolling Now in West Palm Beach, FL
Adults 18 to 79 years of age with type 1 diabetes may qualify to take part in a research study comparing an investigational short-acting mealtime insulin with Humalog insulin for approximately 34 weeks.
Qualified candidates will:
• Be on Multiple Daily lnjections of long and short-acting insulin
• Be willing to use a continuous glucose monitor
• Have access to a Smart Phone
• Receive free Dexcom G7 continuous glucose monitoring systems throughout the study
• Not be on any weight loss medications such as GLP-1 receptor agonists or glucose-modifying medications such as SGL T-2 inhibitors
Additional eligibility criteria also apply.
Participants will be compensated up to $1,000 for their time and travel and will receive insulin at no cost.
For more information call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: www.metabolic-institute.com/type1-diabetes-study/
